Inclusion body myositis is a slowly progressive myopathy affecting predominantly the middle-aged and older patient population. It is a major form of the idiopathic inflammatory myopathies which are chronic systemic autoimmune diseases characterized by symmetrical proximal muscle weakness. Unfortunately, there is no effective therapy yet; however, the early diagnosis is essential to provide treatment options which may significantly slow the progression of the disease. In our case-based clinicopathological study the importance of the close collaboration between the clinician and the neuropathologist is emphasised. © 2013 Versita Sp. z o.o.
CITATION STYLE
Bodoki, L., Vincze, M., Griger, Z., Csonka, T., Murnyák, B., Kurucz, A., … Hortobágyi, T. (2014). Inclusion body myositis-a case based clinicopathological update. Central European Journal of Medicine, 9(1), 80–85. https://doi.org/10.2478/s11536-013-0250-x
Mendeley helps you to discover research relevant for your work.